HealthDay News — The US Food and Drug Administration is urging all patients with smartphone-compatible diabetes devices to check their phone configurations to ensure all safety alerts are being ...

A sensor-augmented pump (SAP) combines the technology of an insulin pump with a continuous glucose sensor, allowing users to monitor glucose and insulin levels simultaneously. Another innovation ...

The Food and Drug Administration Feb. 5 released an alert notifying patients of a safety concern using diabetes devices such ...

Insulin pumps and CGMS provide greater flexibility, improved blood sugar control, and better quality of life for children and ...

Insulin pump market growth is propelled by advancements in technology, rising global diabetes prevalence, and increased demand for precision diabetes management.New Delhi, Feb. 06, 2025 (GLOBE ...

FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible ...

Diabetic students often have glucose monitors connected to phone apps that sound an alarm when they detect a problem, but ...

Patients who use smartphone apps to manage their diabetes could face serious health problems if they miss notifications ...

The US Food and Drug Administration (FDA) is cautioning patients and caregivers about the potential for not receiving blood ...

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

Medicare Part B will cover insulin pumps and insulin if a person meets the necessary criteria. Part D will cover prescription insulin and related medical supplies for diabetes. Under Medicare Part ...

Key market drivers of the Insulin Pen and Pump market include the rising prevalence of diabetes, advancements in insulin delivery technologies ...